Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2004

View Archived Issues

Eisai inlicenses clevudine from Bukwang Pharm

Chiron will not file BLA for Menjugate meningococcal C vaccine

MMV and GlaxoSmithKline to develop GW-844520X for malaria

Rigel and Merck & Co. partner on ubiquitin ligases research for cancer

Namenda sNDA for mild Alzheimer's disease accepted for review

AEOL-10150 enters phase I in ALS

Enrollment closes in Chinese Femprox study

Glufosfamide receives fast track status for pancreatic cancer

TPI-926 enters phase II for CNS disorder

TS-2037 demonstrates potent activity against MRSA

Novel lantibiotic has potent antimicrobial activity

Molecular cloaking technology enhances development of HIV-1 entry inhibitors

Novel von Willebrand factor antagonist prevents occlusive thrombus formation in vivo

Dimiracetam derivative for the treatment of neuropathic pain

Antiinflammatory compound for the treatment of acute ischemic stroke

Thyroid hormone binding protein may provide protection against Alzheimer's disease

New histone deacetylase inhibitors in early development at Syrrx

CCR2 receptor modulators described by Merck

Merck patent claims bradykinin B1 receptor antagonist

Three series of CGRP receptor antagonists claimed by Merck

A series of fused pyrrole compounds described in a patent

Activity of and resistance to antimalarial ferroquine evaluated

K-777 active against Cryptosporidium parvum in vitro and in vivo

Good safety profile found for HyCAMP in colorectal cancer

GW-501516 increases HDL-cholesterol levels in healthy volunteers

Six-year benefits of lopinavir/ritonavir therapy in HIV-infected patients

Uptake of DB-75 in Trypanosoma brucei brucei elucidated

Phase I/II data on the safety of PKC-412 plus imatinib mesylate in GIST

Antirestenotic activity of MS-275 measured in vitro, in vivo

Hemodynamic, renal effects of tolvaptan studied in congestive heart failure model

Antiatherosclerotic activity of S-1627 revealed in two species

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...